Jimmy McBlane

Dr McBlane’s completed degrees in pharmacology and worked for the pharmaceutical firm, Wellcome, moving to the UK Medicines Control Agency and then to the Japanese biopharmaceutical company, Chugai. He returned to the Medicines & Healthcare products Regulatory Agency (MHRA) in 2005, since when he has worked on thousands of clinical trial applications and hundreds of marketing authorisation applications. From 2013, he was alternate UK delegate to the European Medicines Agency’s (EMA) Committee for Advanced Therapies (CAT); in 2018-2019, he was alternate delegate from CAT to EMA’s Scientific Advice Working Party (SAWP). He worked in the MHRA’s Biologicals Unit from 2006-2021.